The HLA system in hematopoietic stem cell transplantation - Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation - page 37

[102] Tamouza R, Rocha V, Busson M, Fortier C, El Sherbini SM, Esperou H, et al. Association
of HLA-E polymorphism with severe bacterial infection and early transplant-related
mortality in matched unrelated bone marrow transplantation. Transplantation
2005;80:140-4.
[103] Ravindranath MH, Pham T, Ozawa M, Terasaki PI. Antibodies to HLA-E may account
for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant
recipients. Int Immunol 2012;24:43-57.
[104] La Nasa G, Littera R, Locatelli F, Lai S, Alba F, Caocci G, et al. The human leucocyte anti-
gen-G 14-basepair polymorphism correlates with graft-versus-host disease in unrelated
bone marrow transplantation for thalassaemia. Br J Haematol 2007;139:284-8.
[105] Chiusolo P, Bellesi S, Piccirillo N, Giammarco S, Marietti S, De Ritis D, et al. The role
of HLA-G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD
prophylaxis. Bone Marrow Transplant 2012;47:120-4.
[106] Boukouaci W, Busson M, Fortier C, Amokrane K, Peffault de Latour R, Robin M, et al.
Association of HLA-G low expressor genotype with severe acute graft-versus-host dis-
ease after sibling bone marrow transplantation. Front Immun 2011;2:1-6.
[107] Larsen MH, Hylenius S, Andersen AM, Hviid TV. The 3′-untranslated region of the HLA-G
gene in relation to pre-eclampsia: revisited. Tissue Antigens 2010;75:253-61.
[108] O'Brien M, McCarthy T, Jenkins D, Paul P, Dausset J, Carosella ED, et al. Altered HLA-G
transcription in pre-eclampsia is associated with allele specific inheritance: possible
role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001;58:1943-9.
[109] Hviid TV, Hylenius S, Rørbye C, Nielsen LG. HLA-G allelic variants are associated with
differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunoge-
netics 2003;55:63-79.
[110] Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp
deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences
HLA-G mRNA stability. Hum Immunol 2003;64:1005-10.
[111] Veit TD, Chies JA. Tolerance versus immune response - microRNAs as important ele-
ments in the regulation of the HLA-G gene expression. Transpl Immunol 2009;20:229-31.
[112] Castelli EC, Mendes-Junior CT, Deghaide NH, de Albuquerque RS, Muniz YC, Simões
RT, et al. The genetic structure of 3′ untranslated region of the HLA-G gene: polymor-
phisms and haplotypes. Genes Immun 2010;11:134-41.
[113] Le Maux A, Noël G, Birebent B, Grosset JM, Vu N, De Guibert S, et al. Soluble human
leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell trans-
plantation: a specific role to prevent acute graft-versus-host disease and a link with
regulatory T cells. Clin Exp Immunol 2008;152:50-6.
[114] Le Rond S, Le Maoult J, Créput C, Menier C, Deschamps M, Le Friec G, et al. Alloreactive
CD4 + and CD8 + T cells express the immunotolerant HLA-G molecule in mixed lymphocyte
reactions: in vivo implications in transplanted patients. Eur J Immunol 2004;34:649-60.
[115] Ristich V, Zhang W, Liang S, Horuzsko A. Mechanisms of prolongation of allograft sur-
vival by HLA-G/ILT4-modified dendritic cells. Hum Immunol 2007;68:264-71.
[116] Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED. Implication of
HLA-G molecule in heart-graft acceptance. Lancet 2000;355:2138.
[117] Crispim JC, Duarte RA, Soares CP, Costa R, Silva JS, Mendes-Júnior CT, et al. Human
leukocyte antigen-G expression after kidney transplantation is associated with a re-
duced incidence of rejection. Transpl Immunol 2008;18:361-7.
[118] Crispim JC, Mendes-Junior CT, Wastowski IJ, Costa R, Castelli EC, Saber LT, et al.
Frequency of insertion/deletion polymorphism in exon 8 of HLA-G and kidney allograft
outcome. Tissue Antigens 2008;71:35-41.
[119] Piancatelli D, Maccarone D, Liberatore G, Parzanese I, Clemente K, Azzarone R, et al.
HLA-G 14-bp insertion/deletion polymorphism in kidney transplant patients with
metabolic complications. Transplant Proc 2009;41:1187-8.
[120] Twito T, Joseph J, Mociornita A, Rao V, Ross H, Delgado DH. The 14-bp deletion in the
HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipi-
ents. J Heart Lung Transplant 2011;30:778-82.
[121] Boukouaci W, Busson M, Peffault de Latour R, Rocha V, Suberbielle C, Bengoufa D, et al.
MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic
graft-versus-host disease. Blood 2009;114:5216-24.
[122] Parmar S, Del Lima M, Zou Y, Patah PA, Liu P, Cano P, et al. Donor-recipient mis-
matches in MHC class I chain-related gene A in unrelated donor transplantation lead
to increased incidence of acute graft-versus-host disease. Blood 2009;114:2884-7.
[123] Novota P, Zinëcker S, Norden J, Wang XN, Sviland L, Opitz L, et al. Expression profiling
of major histocompatibility and natural killer complex genes reveals candidates for
controlling risk of graft versus host disease. PLoS One 2011;6:e16582.
[124] Charron D. HLA, immunogenetics, pharmacogenetics and personalized medicine. Vox
Sang 2011;100:163-6.

38